Relative Contraindication to Endoscopic Subureteral Injection for Vesicoureteral Reflux: Congenital Refluxing Megaureter with Distal Aperistaltic Segment
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- The Role of Endoscopic Treatment in the Management of Grade V Primary Vesicoureteral RefluxEuropean Urology, 2007
- Are there predictive factors for the outcome of endoscopic treatment of grade III–V vesicoureteral reflux with dextranomer/hyaluronic acid in children?Pediatric Surgery International, 2007
- Endoscopic Treatment With Stabilized Nonanimal Hyaluronic Acid/Dextranomer Gel is Effective in Vesicoureteral Reflux Associated With Bladder DysfunctionJournal of Urology, 2007
- Postoperative Ureteral Obstruction After Subureteral Injection of Dextranomer/Hyaluronic Acid CopolymerJournal of Urology, 2006
- Ureteral obstruction after dextranomer/hyaluronic acid copolymer injection for treatment of secondary vesicoureteral reflux after renal transplantationUrology, 2006
- THE MODIFIED STING PROCEDURE TO CORRECT VESICOURETERAL REFLUX: IMPROVED RESULTS WITH SUBMUCOSAL IMPLANTATION WITHIN THE INTRAMURAL URETERJournal of Urology, 2004
- Treatment of vesico‐ureteric reflux: a new algorithm based on parental preferenceBJU International, 2003
- Minimally Invasive Treatment of Vesicoureteral Reflux with Endoscopic Injection of Dextranomer/Hyaluronic Acid Copolymer: The Children’s Hospitals of Atlanta ExperienceJournal of Urology, 2003
- LONG-TERM FOLLOWUP OF CHILDREN TREATED WITH DEXTRANOMER/HYALURONIC ACID COPOLYMER FOR VESICOURETERAL REFLUXJournal of Urology, 2001
- PARENTAL PREFERENCES IN THE MANAGEMENT OF VESICOURETERAL REFLUXJournal of Urology, 2001